3/19
06:20 am
indv
Indivior (INDV) was upgraded by Zacks Research from "hold" to "strong-buy".
Low
Report
Indivior (INDV) was upgraded by Zacks Research from "hold" to "strong-buy".
3/18
06:39 pm
indv
Indivior (INDV) was downgraded by
Weiss Ratings from "buy (b-)" to "hold (c+)".
Low
Report
Indivior (INDV) was downgraded by
Weiss Ratings from "buy (b-)" to "hold (c+)".
3/17
12:36 pm
indv
National Survey Finds Only 58% of U.S. Correctional Facilities Offer Medications for Opioid Use Disorder [Yahoo! Finance]
Low
Report
National Survey Finds Only 58% of U.S. Correctional Facilities Offer Medications for Opioid Use Disorder [Yahoo! Finance]
3/17
12:01 pm
indv
National Survey Finds Only 58% of U.S. Correctional Facilities Offer Medications for Opioid Use Disorder
Low
Report
National Survey Finds Only 58% of U.S. Correctional Facilities Offer Medications for Opioid Use Disorder
3/15
04:30 am
indv
How Indivior's Upsized $450 Million Convertible Notes and Buybacks May Impact Indivior (INDV) Investors [Yahoo! Finance]
Low
Report
How Indivior's Upsized $450 Million Convertible Notes and Buybacks May Impact Indivior (INDV) Investors [Yahoo! Finance]
3/12
09:15 pm
indv
Indivior Prices Upsized $450.0 Million Convertible Senior Notes Offering [Yahoo! Finance]
Low
Report
Indivior Prices Upsized $450.0 Million Convertible Senior Notes Offering [Yahoo! Finance]
3/12
08:30 pm
indv
Indivior Prices Upsized $450.0 Million Convertible Senior Notes Offering
Low
Report
Indivior Prices Upsized $450.0 Million Convertible Senior Notes Offering
3/12
07:45 am
indv
Indivior Announces Proposed Convertible Senior Notes Offering [Yahoo! Finance]
Low
Report
Indivior Announces Proposed Convertible Senior Notes Offering [Yahoo! Finance]
3/12
07:00 am
indv
Indivior Announces Proposed Convertible Senior Notes Offering
Low
Report
Indivior Announces Proposed Convertible Senior Notes Offering
3/11
09:27 am
indv
New Study Shows Adherence to Monthly Injectable Buprenorphine Linked to Lower Healthcare Utilization and Costs in Opioid Use Disorder [Yahoo! Finance]
Low
Report
New Study Shows Adherence to Monthly Injectable Buprenorphine Linked to Lower Healthcare Utilization and Costs in Opioid Use Disorder [Yahoo! Finance]
3/11
09:00 am
indv
New Study Shows Adherence to Monthly Injectable Buprenorphine Linked to Lower Healthcare Utilization and Costs in Opioid Use Disorder
Low
Report
New Study Shows Adherence to Monthly Injectable Buprenorphine Linked to Lower Healthcare Utilization and Costs in Opioid Use Disorder
3/3
06:13 pm
indv
Indivior (INDV) was upgraded by
Weiss Ratings from "hold (c)" to "buy (b-)".
Medium
Report
Indivior (INDV) was upgraded by
Weiss Ratings from "hold (c)" to "buy (b-)".
2/27
07:13 am
indv
Indivior PLC Q4 2025 Earnings Call Summary [Yahoo! Finance]
Medium
Report
Indivior PLC Q4 2025 Earnings Call Summary [Yahoo! Finance]
2/27
12:00 am
indv
A Look At Indivior Pharmaceuticals (NasdaqGS:INDV) Valuation After Its Recent Name Change [Yahoo! Finance]
Medium
Report
A Look At Indivior Pharmaceuticals (NasdaqGS:INDV) Valuation After Its Recent Name Change [Yahoo! Finance]
2/26
09:43 am
indv
Indivior Q4 Earnings Call Highlights [Yahoo! Finance]
Low
Report
Indivior Q4 Earnings Call Highlights [Yahoo! Finance]
2/26
07:09 am
indv
Indivior Reports Fourth Quarter and Full-Year 2025 Financial Results [Yahoo! Finance]
Medium
Report
Indivior Reports Fourth Quarter and Full-Year 2025 Financial Results [Yahoo! Finance]
2/26
07:00 am
indv
Indivior Reports Fourth Quarter and Full-Year 2025 Financial Results
Low
Report
Indivior Reports Fourth Quarter and Full-Year 2025 Financial Results
2/24
07:00 am
indv
Indivior to Participate in Upcoming Investor Conferences
Low
Report
Indivior to Participate in Upcoming Investor Conferences
1/30
06:06 am
indv
Indivior (NASDAQ:INDV) had its "hold (c)" rating reaffirmed by analysts at
Weiss Ratings.
Low
Report
Indivior (NASDAQ:INDV) had its "hold (c)" rating reaffirmed by analysts at
Weiss Ratings.
1/28
10:48 am
indv
Indivior to Report Fourth Quarter and Full-Year 2025 Financial Results and Host Webcast on February 26?? [Yahoo! Finance]
Low
Report
Indivior to Report Fourth Quarter and Full-Year 2025 Financial Results and Host Webcast on February 26?? [Yahoo! Finance]
1/28
07:00 am
indv
Indivior to Report Fourth Quarter and Full-Year 2025 Financial Results and Host Webcast on February 26??
Low
Report
Indivior to Report Fourth Quarter and Full-Year 2025 Financial Results and Host Webcast on February 26??
1/26
07:08 am
indv
Indivior Announces Completion of Redomiciliation to the United States [Yahoo! Finance]
Low
Report
Indivior Announces Completion of Redomiciliation to the United States [Yahoo! Finance]
1/26
07:00 am
indv
Indivior Announces Completion of Redomiciliation to the United States
Low
Report
Indivior Announces Completion of Redomiciliation to the United States
1/21
02:37 pm
indv
MRNA is S&P 500's top performing stock, here are the best Quant pharma companies [Seeking Alpha]
Low
Report
MRNA is S&P 500's top performing stock, here are the best Quant pharma companies [Seeking Alpha]
1/20
11:14 am
indv
Indivior (NASDAQ:INDV) was given a new $50.00 price target on by analysts at Northland Securities.
Low
Report
Indivior (NASDAQ:INDV) was given a new $50.00 price target on by analysts at Northland Securities.